Yüklüyor......

Targeting the Ras pathway in pediatric hematologic malignancies

PURPOSE: Ras pathway mutations are one of the most common type of alterations in pediatric hematologic malignancies and are frequently associated with adverse outcomes. Despite ongoing efforts to use targeted treatments, there remain no food and drug administration (FDA) approved medications specifi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Opin Pediatr
Asıl Yazarlar: Pikman, Yana, Stieglitz, Elliot
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7880552/
https://ncbi.nlm.nih.gov/pubmed/33394740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000981
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!